Gastrointestinal stability of urolithins: an in vitro approach

European Journal of Nutrition

Volumn 56, Issue 1, 2017, Pages 99-106

  Mena, Pedro ^a   Dall’Asta, Margherita ^a   Calani, Luca ^a   Brighenti, Furio ^a   Del Rio, Daniele ^a,b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bioaccessibility; Colonic fermentation; Ellagic acid; Ellagitannin; Gastrointestinal tract; Microbial metabolite

Indexed keywords

DRUG METABOLITE; ELLAGIC ACID; ELLAGITANNIN; GLUCURONIC ACID; PANCREATIN; UNCLASSIFIED DRUG; UROLITHIN A; UROLITHIN B; UROLITHIN B GLUCURONIDE; 3,8-DIHYDROXY-6H-DIBENZO(B,D)PYRAN-6-ONE; COUMARIN DERIVATIVE; GLUCURONIDE; TANNIN;

ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; COLON EPITHELIUM; CONTROLLED STUDY; DIGESTION; DRUG CONJUGATION; DRUG FECES LEVEL; DRUG ISOLATION; DRUG STABILITY; DRUG STRUCTURE; GASTROINTESTINAL TRACT; IN VITRO STUDY; INTESTINE FLORA; MASS SPECTROMETRY; PARTICLE SIZE; SMALL INTESTINE; SOLVENT EXTRACTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BIOLOGICAL MODEL; CHEMICAL PHENOMENA; COLON; FECES; FERMENTATION; HUMAN; METABOLISM; MICROBIOLOGY;

CHEMICAL PHENOMENA; COLON; COUMARINS; DIGESTION; ELLAGIC ACID; FECES; FERMENTATION; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GLUCURONIDES; HUMANS; HYDROLYZABLE TANNINS; MODELS, BIOLOGICAL;

EID: 84944584553     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-1061-4     Document Type: Article

References (43)

1. Mena P, Calani L, Bruni R, Del Rio D (2015) Chapter 6—Bioactivation of high-molecular-weight polyphenols by the gut microbiome. In: Rio D, Tuohy K (eds) Diet-microbe interactions in the gut. Academic Press, San Diego, pp 73–101. doi:10.1016/B978-0-12-407825-3.00006-X
2. Rodriguez-Mateos A, Vauzour D, Krueger CG, Shanmuganayagam D, Reed J, Calani L, Mena P, Del Rio D, Crozier A (2014) Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Arch Toxicol 88(10):1803–1853. doi:10.1007/s00204-014-1330-7
3. Zanotti I, Dall’Asta M, Mena P, Mele L, Bruni R, Ray S, Del Rio D (2015) Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism. Food Funct 6(1):13–31. doi:10.1039/c4fo00670d
4. Giménez-Bastida JA, González-Sarrías A, Larrosa M, Tomás-Barberán F, Espín JC, García-Conesa MT (2012) Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells. Mol Nutr Food Res 56(5):784–796. doi:10.1002/mnfr.201100677
5. Giménez-Bastida JA, Larrosa M, González-Sarrías A, Tomás-Barberán F, Espín JC, García-Conesa MT (2012) Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts. J Agric Food Chem 60(36):8866–8876. doi:10.1021/jf300290f
6. Verzelloni E, Pellacani C, Tagliazucchi D, Tagliaferri S, Calani L, Costa LG, Brighenti F, Borges G, Crozier A, Conte A, Del Rio D (2011) Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites. Mol Nutr Food Res 55(SUPPL. 1):S35–S43. doi:10.1002/mnfr.201000525
7. González-Sarrías A, Larrosa M, Tomás-Barberán FA, Dolara P, Espín JC (2010) NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br J Nutr 104(4):503–512. doi:10.1017/S0007114510000826
8. Piwowarski JP, Granica S, Kiss AK (2014) Influence of gut microbiota-derived ellagitannins metabolites urolithins on pro-inflammatory activities of human neutrophils. Planta Med 80(11):887–895. doi:10.1055/s-0034-1368615
9. Piwowarski JP, Granica S, Zwierzyńska M, Stefańska J, Schopohl P, Melzig MF, Kiss AK (2014) Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials. J Ethnopharmacol 155(1):801–809. doi:10.1016/j.jep.2014.06.032
10. Sala R, Mena P, Savi M, Brighenti F, Crozier A, Miragoli M, Stilli D, Del Rio D (2015) Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions. J Funct Food 15:97–105. doi:10.1016/j.jff.2015.03.019
11. González-Sarrías A, Azorín-Ortuño M, Yáñez-Gascón MJ, Tomás-Barberán FA, García-Conesa MT, Espín JC (2009) Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1. J Agric Food Chem 57(12):5623–5632. doi:10.1021/jf900725e
12. Kasimsetty SG, Blalonska D, Reddy MK, Ma G, Khan SI, Ferreira D (2010) Colon cancer chemopreventive activities of pomegranate ellagitannins and Urolithins. J Agric Food Chem 58(4):2180–2187. doi:10.1021/jf903762h
13. Seeram NP, Aronson WJ, Zhang Y, Henning SM, Moro A, Lee RP, Sartippour M, Harris DM, Rettig M, Suchard MA, Pantuck AJ, Belldegrun A, Heber D (2007) Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem 55(19):7732–7737. doi:10.1021/jf071303g
14. Dellafiora L, Mena P, Cozzini P, Brighenti F, Del Rio D (2013) Modelling the possible bioactivity of ellagitannin-derived metabolites. In silico tools to evaluate their potential xenoestrogenic behavior. Food Funct 4(10):1442–1451. doi:10.1039/c3fo60117j
15. Larrosa M, González-Sarrías A, García-Conesa MT, Tomás-Barberán FA, Espín JC (2006) Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 54(5):1611–1620. doi:10.1021/jf0527403
16. Puupponen-Pimiä R, Seppänen-Laakso T, Kankainen M, Maukonen J, Törrönen R, Kolehmainen M, Leppänen T, Moilanen E, Nohynek L, Aura A-M, Poutanen K, Tómas-Barberán FA, Espín JC, Oksman-Caldentey K-M (2013) Effects of ellagitannin-rich berries on blood lipids, gut microbiota, and urolithin production in human subjects with symptoms of metabolic syndrome. Mol Nutr Food Res 57(12):2258–2263. doi:10.1002/mnfr.201300280
17. González-Sarrías A, Giménez-Bastida JA, Garcíaa-Conesa MT, Gómez-Sánchez MB, García-Talavera NV, Gil-Izquierdo A, Sánchez-Álvarez C, Fontana-Compiano LO, Morga-Egea JP, Pastor-Quirante FA, Martínez-Díaz F, Tomás-Barberán FA, Espín JC (2010) Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. Mol Nutr Food Res 54(3):311–322. doi:10.1002/mnfr.200900152
18. González-Barrio R, Edwards CA, Crozier A (2011) Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: in vivo and in vitro studies. Drug Metab Dispos 39(9):1680–1688. doi:10.1124/dmd.111.039651
19. García-Villalba R, Beltrán D, Espín JC, Selma MV, Tomás-Barberán FA (2013) Time course production of urolithins from ellagic acid by human gut microbiota. J Agric Food Chem 61(37):8797–8806. doi:10.1021/jf402498b
20. García-Muñoz C, Hernández L, Pérez A, Vaillant F (2014) Diversity of urinary excretion patterns of main ellagitannins’ colonic metabolites after ingestion of tropical highland blackberry (Rubus adenotrichus) juice. Food Res Int 55:161–169. doi:10.1016/j.foodres.2013.10.049
21. Nuñez-Sanchez MA, Garcia-Villalba R, Monedero-Saiz T, Garcia-Talavera NV, Gomez-Sanchez MB, Sanchez-Alvarez C, Garcia-Albert AM, Rodriguez-Gil FJ, Ruiz-Marin M, Pastor-Quirante FA, Martinez-Diaz F, Yanez-Gascon MJ, Gonzalez-Sarrias A, Tomas-Barberan FA, Espin JC (2014) Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Mol Nutr Food Res. doi:10.1002/mnfr.201300931
22. González-Barrio R, Borges G, Mullen W, Crozier A (2010) Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy. J Agric Food Chem 58(7):3933–3939. doi:10.1021/jf100315d
23. Tulipani S, Urpi-Sarda M, García-Villalba R, Rabassa M, López-Uriarte P, Bulló M, Jáuregui O, Tomás-Barberán F, Salas-Salvadó J, Espín JC, Andrés-Lacueva C (2012) Urolithins are the main urinary microbial-derived phenolic metabolites discriminating a moderate consumption of nuts in free-living subjects with diagnosed metabolic syndrome. J Agric Food Chem 60(36):8930–8940. doi:10.1021/jf301509w
24. Truchado P, Larrosa M, García-Conesa MT, Cerdá B, Vidal-Guevara ML, Tomás-Barberán FA, Espín JC (2012) Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans. J Agric Food Chem 60(23):5749–5754. doi:10.1021/jf203641r
25. Tomás-Barberán FA, García-Villalba R, González-Sarrías A, Selma MV, Espín JC (2014) Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J Agric Food Chem 62(28):6535–6538. doi:10.1021/jf5024615
26. Selma MV, Beltran D, Garcia-Villalba R, Espin JC, Tomas-Barberan FA (2014) Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species. Food Funct 5(8):1779–1784. doi:10.1039/c4fo00092g
27. Gil-Izquierdo A, Zafrilla P, Tomás-Barberán FA (2002) An in vitro method to simulate phenolic compound release from the food matrix in the gastrointestinal tract. Eur Food Res Technol 214(2):155–159. doi:10.1007/s00217-001-0428-3
28. Versantvoort CHM, Oomen AG, Van De Kamp E, Rompelberg CJM, Sips AJAM (2005) Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food. Food Chem Toxicol 43(1):31–40. doi:10.1016/j.fct.2004.08.007
29. Dall’Asta M, Calani L, Tedeschi M, Jechiu L, Brighenti F, Del Rio D (2012) Identification of microbial metabolites derived from invitro fecal fermentation of different polyphenolic food sources. Nutrition 28(2):197–203. doi:10.1016/j.nut.2011.06.005
30. Bermúdez-Soto MJ, Tomás-Barberán FA, García-Conesa MT (2007) Stability of polyphenols in chokeberry (Aronia melanocarpa) subjected to in vitro gastric and pancreatic digestion. Food Chem 102(3):865–874. doi:10.1016/j.foodchem.2006.06.025
31. Coates EM, Popa G, Gill CIR, McCann MJ, McDougall GJ, Stewart D, Rowland I (2007) Colon-available raspberry polyphenols exhibit anti-cancer effects on in vitro models of colon cancer. J Carcinog 6:4. doi:10.1186/1477-3163-6-4
32. Niino H, Sakane I, Okanoya K, Kuribayashi S, Kinugasa H (2005) Determination of mechanism of flock sediment formation in tea beverages. J Agric Food Chem 53(10):3995–3999. doi:10.1021/jf047904e
33. Stern JL, Hagerman A, Steinberg P, Mason P (1996) Phlorotannin-protein interactions. J Chem Ecol 22(10):1877–1899. doi:10.1007/bf02028510
34. Daniel EM, Ratnayake S, Kinstle T, Stoner GD (1991) The effects of pH and rat intestinal contents on the liberation of ellagic acid from purified and crude ellagitannins. J Nat Prod 54(4):946–952. doi:10.1021/np50076a004
35. Bacon JR, Rhodes MJC (2000) Binding affinity of hydrolyzable tannins to parotid saliva and to proline-rich proteins derived from it. J Agric Food Chem 48(3):838–843. doi:10.1021/jf990820z
36. Rinaldi A, Gambuti A, Moio L (2012) Precipitation of salivary proteins after the interaction with wine: the effect of ethanol, pH, fructose, and mannoproteins. J Food Sci 77(4):C485–C490. doi:10.1111/j.1750-3841.2012.02639.x
37. Lu Y, Bennick A (1998) Interaction of tannin with human salivary proline-rich proteins. Arch Oral Biol 43(9):717–728. doi:10.1016/s0003-9969(98)00040-5
38. McRae JM, Kennedy JA (2011) Wine and grape tannin interactions with salivary proteins and their impact on astringency: a review of current research. Molecules 16(3):2348–2364. doi:10.3390/molecules16032348
39. Tagliazucchi D, Verzelloni E, Bertolini D, Conte A (2010) In vitro bio-accessibility and antioxidant activity of grape polyphenols. Food Chem 120(2):599–606. doi:10.1016/j.foodchem.2009.10.030
40. Woodward GM, Needs PW, Kay CD (2011) Anthocyanin-derived phenolic acids form glucuronides following simulated gastrointestinal digestion and microsomal glucuronidation. Mol Nutr Food Res 55(3):378–386. doi:10.1002/mnfr.201000355
41. Boyer J, Brown D, Liu R (2005) In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the Caco-2 cell monolayer. Nutr J 4(1):1. doi:10.1186/1475-2891-4-1
42. Aura A-M (2008) Microbial metabolism of dietary phenolic compounds in the colon. Phytochem Rev 7(3):407–429. doi:10.1007/s11101-008-9095-3
43. Rubió L, Macià A, Motilva MJ (2014) Impact of various factors on pharmacokinetics of bioactive polyphenols: an overview. Curr Drug Metab 15(1):62–76. doi:10.2174/1389200214666131210144115